Regenerex Pharma, Inc. - Form 8-K Filing Summary

Regenerex Pharma, Inc. has announced the resignation of its independent registered public accounting firm, dbbmckennon, effective August 31, 2026. dbbmckennon had served as the Company's auditor since 2017. The resignation was a mutual decision, and the Company has acknowledged and accepted it. dbbmckennon's reports for the fiscal years ended December 31, 2025, and March 31, 2025, did not contain adverse opinions but did include explanatory paragraphs regarding substantial doubt about the Company's ability to continue as a going concern and a revision to financial statements for related party transactions. There were no disagreements or reportable events between the Company and dbbmckennon. Regenerex Pharma, Inc. is in the process of engaging a successor accounting firm to complete its outstanding financial reporting obligations and periodic reports.